Skip to content

TENS in the management of obesity

Effect of transcutaneous electrical nerve stimulation of T6 dermatome on appetite and weight reduction in obese individuals: a pilot study - TENSOBESE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020858
Enrollment
20
Registered
2019-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Transcutaneous electrical nerve stimulation (TENS) of T6 dermatome will be done.: A caliberated TENS equipment will be used to stimulate the T6 dermatome. The parameters of TENS select

Sponsors

Dr Deepak Agrawal
Lead Sponsor
Pradeep Kumar Sahu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. BMI > 30 kg/m2 2. Appetite level on VAS >= 3 3. Dietary treatment failure

Exclusion criteria

Exclusion criteria: 1. Any known endocrine disease resulting in obesity 2. Evidence of metabolic, neurological, psychiatric, gynecological and cardiovascular disorders 3. Any evidence of infection or malignant conditions 4. Previous abdominal surgeries 5. Withdrawal of consent

Design outcomes

Primary

MeasureTime frame
1. Appetite level: A visual analogue scale (VAS) will be used to measure the appetite level. The scale is caliberated from 0 to 100 with mm interval. VAS (0mm) is considered as "not at all hungry and (100 mm) is "as hungry as I have ever felt". The other side of the scale with marking only 0 and 100 will be shown to subjects and they will mark their current appetite level.Timepoint: 1. Baseline 2. on each intervention session 3. 8 weeks after the final intervetion

Secondary

MeasureTime frame
1. Weight will be measured by caliberated standardized weigh machine. 2. BMI: After weight and height measurement by measuring tools,BMI will be calculated.Timepoint: 1. Baseline 2. on each intervention session 3. 8 weeks after the final intervetion

Countries

India

Contacts

Public ContactPradeep Kumar Sahu

All India Institute of Medical Sciences, New Delhi

pksahu9938@gmail.com8384065426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026